CAPREOMYCIN: 398 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
398
Total FAERS Reports
107 (26.9%)
Deaths Reported
148
Hospitalizations
398
As Primary/Secondary Suspect
51
Life-Threatening
9
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
Yes
Generic Available
FDA Application: 050095 ·
First Report: 2011 · Latest Report: 20230505
What Are the Most Common CAPREOMYCIN Side Effects?
#1 Most Reported
Electrocardiogram qt prolonged
74 reports (18.6%)
#2 Most Reported
Off label use
53 reports (13.3%)
#3 Most Reported
Drug resistance
49 reports (12.3%)
All CAPREOMYCIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Electrocardiogram qt prolonged | 74 | 18.6% | 15 | 28 |
| Off label use | 53 | 13.3% | 15 | 17 |
| Drug resistance | 49 | 12.3% | 8 | 6 |
| Vomiting | 34 | 8.5% | 4 | 17 |
| Anaemia | 29 | 7.3% | 5 | 9 |
| Neuropathy peripheral | 28 | 7.0% | 5 | 8 |
| Hepatotoxicity | 27 | 6.8% | 1 | 6 |
| Intentional product use issue | 24 | 6.0% | 11 | 8 |
| Nausea | 24 | 6.0% | 3 | 9 |
| Dyspnoea | 22 | 5.5% | 13 | 13 |
| Product use in unapproved indication | 22 | 5.5% | 3 | 7 |
| Hypokalaemia | 19 | 4.8% | 5 | 10 |
| Tuberculosis | 19 | 4.8% | 12 | 2 |
| Gastrointestinal disorder | 18 | 4.5% | 5 | 7 |
| Treatment failure | 18 | 4.5% | 8 | 6 |
| Asthenia | 17 | 4.3% | 7 | 5 |
| Blood creatinine increased | 16 | 4.0% | 3 | 4 |
| Respiratory failure | 16 | 4.0% | 15 | 4 |
| Tinnitus | 14 | 3.5% | 2 | 0 |
| Treatment noncompliance | 14 | 3.5% | 7 | 7 |
Who Reports CAPREOMYCIN Side Effects? Age & Gender Data
Gender: 49.5% female, 50.5% male. Average age: 36.1 years. Most reports from: CN. View detailed demographics →
Is CAPREOMYCIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 0 | 2 |
| 2014 | 4 | 1 | 0 |
| 2015 | 7 | 2 | 3 |
| 2016 | 32 | 11 | 11 |
| 2017 | 52 | 16 | 29 |
| 2018 | 74 | 17 | 39 |
| 2019 | 34 | 12 | 12 |
| 2020 | 4 | 1 | 3 |
| 2021 | 1 | 0 | 0 |
| 2022 | 1 | 0 | 0 |
| 2023 | 1 | 0 | 0 |
What Is CAPREOMYCIN Used For?
| Indication | Reports |
|---|---|
| Tuberculosis | 284 |
| Pulmonary tuberculosis | 82 |
| Lymph node tuberculosis | 7 |
| Product used for unknown indication | 6 |
| Meningitis tuberculous | 5 |
CAPREOMYCIN vs Alternatives: Which Is Safer?
CAPREOMYCIN vs CAPSAICIN
CAPREOMYCIN vs CAPTOPRIL
CAPREOMYCIN vs CARBAMAZEPINE
CAPREOMYCIN vs CARBETOCIN
CAPREOMYCIN vs CARBIDOPA
CAPREOMYCIN vs CARBIDOPA\ENTACAPONE\LEVODOPA
CAPREOMYCIN vs CARBIDOPA\LEVODOPA
CAPREOMYCIN vs CARBIMAZOLE
CAPREOMYCIN vs CARBOCYSTEINE
CAPREOMYCIN vs CARBOMER
Official FDA Label for CAPREOMYCIN
Official prescribing information from the FDA-approved drug label.